BRAZIKUMAB
UNII 50EI9G8Q6U

Substance Identification & Data

This profile provides standardized clinical and technical data for Brazikumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 50EI9G8Q6U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1610353-18-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
50EI9G8Q6U
CAS Registry Number
1610353-18-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRAZIKUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C166795
National Cancer Institute reference terminology for clinical and research data.
INN ID
10425
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
CD-125
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brazikumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRAZIKUMAB

Common Names & Synonyms

BRAZIKUMAB [INN]
BRAZIKUMAB [USAN]
BRAZIKUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G2, ANTI-(HUMAN INTERLEUKIN 23) (HUMAN MONOCLONAL MEDI2070 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI2070 .LAMBDA.-CHAIN, DIMER

Technical Codes

MEDI-2070

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus